학술논문
LIGHTHOUSE (OP-108): A phase 3 study of melflufen in combination with dexamethasone (dex) and daratumumab (dara) versus dara in relapsed/refractory multiple myeloma (RRMM) patients (pts).
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755